Nintedanib and pirfenidone for idiopathic pulmonary fibrosis in King Abdulaziz Medical City, Riyadh: Real-life data

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic progressive age-related lung disease causing relentless fibrosis of the lung parenchyma. Currently, pirfenidone and nintedanib are the two antifibrotic drugs, approved for the treatment of IPF. Both are shown to slow progression by preserv...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Mohammed Ayaz, Sherbini, Nahed, Alyami, Sami, Al-Harbi, Abdullah, Al-Ghamdi, Majed, Alrajhi, Suliman, Rajendram, Rajkumar, Al-Jahdali, Hamdan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034822/
https://www.ncbi.nlm.nih.gov/pubmed/36968327
http://dx.doi.org/10.4103/atm.atm_206_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034822/
https://www.ncbi.nlm.nih.gov/pubmed/36968327
http://dx.doi.org/10.4103/atm.atm_206_22

Ejemplares similares